BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
BACKGROUND:The molecular mechanisms driving the papillary thyroid carcinoma (PTC) are still poorly understood. The most frequent genetic alteration in PTC is the BRAFV600E mutation--its impact may extend even beyond PTC genomic profile and influence the tumor characteristics and even clinical behavi...
Main Authors: | Dagmara Rusinek, Michal Swierniak, Ewa Chmielik, Monika Kowal, Malgorzata Kowalska, Renata Cyplinska, Agnieszka Czarniecka, Wojciech Piglowski, Joanna Korfanty, Mykola Chekan, Jolanta Krajewska, Sylwia Szpak-Ulczok, Michal Jarzab, Wieslawa Widlak, Barbara Jarzab |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4666467?pdf=render |
Similar Items
-
The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors.
by: Agnieszka Czarniecka, et al.
Published: (2015-01-01) -
Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
by: Dagmara Rusinek, et al.
Published: (2017-08-01) -
Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
by: Dagmara Rusinek, et al.
Published: (2018-09-01) -
Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma—Do They Exist?
by: Sylwia Szpak-Ulczok, et al.
Published: (2020-06-01) -
<i>TERT</i> Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
by: Dagmara Rusinek, et al.
Published: (2020-06-01)